Drug formulations-lipid for targeted drug delivery to lymphoid and myeloid immune cells.

摘要

A lipid-drug comprising a drug and further comprising targeting ligands in an outer surface which specifically bind to the surface of an immune cell at least one combination of the following markers complex: CD209 and CD4; or CD209 and CD45R0 wherein said drug is an immunomodulatory agent that is active in an immune cell which is directed or he said targeting ligand and wherein said targeting ligand is a monoclonal antibody.